SVRA
Savara Inc
NASDAQ · Healthcare · Biotechnology · US
$5.37
−0.92%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.16
- Revenue estimate
- $500.0K
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.16
- EPS estimate
- -$0.14
- Revenue actual
- —
- Revenue estimate
- $2.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- -11.2%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.14 | -$0.16 | Miss -13.27% | — |
| May 13, 2026 | -$0.14 | -$0.15 | Miss -7.14% | — |
| Nov 12, 2025 | -$0.13 | -$0.14 | Miss -7.69% | — |
| Aug 13, 2025 | -$0.12 | -$0.14 | Miss -16.67% | — |
| Mar 27, 2025 | -$0.11 | -$0.13 | Miss -18.18% | $272.0K |
| May 9, 2024 | -$0.10 | -$0.11 | Miss -10.00% | — |
| Mar 7, 2024 | -$0.11 | -$0.09 | Beat 18.18% | — |
| Nov 9, 2023 | -$0.07 | -$0.10 | Miss -42.86% | — |
| Aug 10, 2023 | -$0.08 | -$0.07 | Beat 12.50% | — |
| May 15, 2023 | -$0.07 | -$0.07 | In line | — |
| Nov 10, 2022 | -$0.07 | -$0.07 | In line | — |
| Aug 11, 2022 | -$0.06 | -$0.06 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026